financetom
Business
financetom
/
Business
/
Maximus Fiscal Q4 Adjusted Earnings, Revenue Rise; Fiscal 2025 Outlook Set -- Shares Fall After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Maximus Fiscal Q4 Adjusted Earnings, Revenue Rise; Fiscal 2025 Outlook Set -- Shares Fall After Hours
Nov 20, 2024 7:28 PM

05:35 PM EST, 11/20/2024 (MT Newswires) -- Maximus ( MMS ) reported fiscal Q4 adjusted earnings late Wednesday of $1.46 per diluted share, up from $1.29 a year earlier.

Two analysts polled by FactSet expected $1.48.

Revenue for the quarter ended Sept. 30 rose to $1.32 billion from $1.26 billion a year earlier.

Two analysts surveyed by FactSet expected $1.31 billion.

For fiscal 2025, the company expects adjusted EPS of $5.70 to $6 on revenue of $5.28 billion to $5.43 billion.

Two analysts polled by FactSet expect $5.96 and $5.36 billion, respectively.

The company's shares were down 6.8% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing
Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing
Sep 21, 2024
04:08 PM EDT, 09/20/2024 (MT Newswires) -- Edward Stewart, Director, on September 20, 2024, sold 2,800 shares in Rbc Bearings ( RBC ) for $837,202. Following the Form 4 filing with the SEC, Stewart has control over a total of 20,461 shares of the company, with 20,461 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1324948/000159396824001214/xslF345X05/primary_01.xml Price: 295.45, Change: +0.11, Percent Change: +0.04...
Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition
Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition
Sep 21, 2024
03:56 PM EDT, 09/20/2024 (MT Newswires) -- Blank-check firm FutureTech II Acquisition ( FTII ) agreed to a merger agreement earlier this week and take Longevity Biomedical public, the companies said Friday. The combined company will operate as Longevity Biomedical and is expected to list on Nasdaq under the LBIO ticker, the companies said. The new company will have approximately...
Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing
Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing
Sep 21, 2024
04:09 PM EDT, 09/20/2024 (MT Newswires) -- Charles Dutil, Director, on September 18, 2024, sold 12,500 shares in Rev Group ( REVG ) for $356,250. Following the Form 4 filing with the SEC, Dutil has control over a total of 41,628 shares of the company, with 41,628 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1687221/000095010324013803/xslF345X05/dp218237_4.xml Price: 27.61, Change: -0.01, Percent Change: -0.04...
Sanofi wins US approval for drug combination to treat multiple myeloma
Sanofi wins US approval for drug combination to treat multiple myeloma
Sep 21, 2024
Sept 20 - Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed multiple myeloma, where it has previously been used only after standard treatments have failed, the U.S. Food and Drug Administration said on Friday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved